TICKERNOMICS Sign up
Last Update: 2024-12-27 15:28:31
Bellevue Life Sciences Acquisition Corp. ( BLAC )
11.28USD
Sector:
Financial Services
Industry:
Shell Companies
Country:
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
BLAC
7.63%
SPY
32.66%
BLAC
0.00%
SPY
108.59%
BLAC
0.00%
SPY
302.52%
BLAC
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
45.58
45.57
0.00
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-96.00
0.00
3.06
-4.46
0.00
-26.07
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
-11.71
-10.62
0.00
Other Earnings and Cash Flow Stats:
Bellevue Life Sciences Acquisition Corp. ( BLAC ) Net Income TTM ($MM) is -0.47
Bellevue Life Sciences Acquisition Corp. ( BLAC ) Operating Income TTM ($MM) is -2.24
Bellevue Life Sciences Acquisition Corp. ( BLAC ) Owners' Earnings Annual ($MM) is 0.00
Bellevue Life Sciences Acquisition Corp. ( BLAC ) Current Price to Owners' Earnings ratio is 0.00
Bellevue Life Sciences Acquisition Corp. ( BLAC ) EBITDA TTM ($MM) is -2.20
Bellevue Life Sciences Acquisition Corp. ( BLAC ) EBITDA Margin is 0.00%
Capital Allocation:
Bellevue Life Sciences Acquisition Corp. ( BLAC ) has paid 0.00 dividends per share and bought back 5.013779 million shares in the past 12 months
Bellevue Life Sciences Acquisition Corp. ( BLAC ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
Bellevue Life Sciences Acquisition Corp. ( BLAC ) Interest-bearing Debt ($MM) as of last quarter is 0
Bellevue Life Sciences Acquisition Corp. ( BLAC ) Annual Working Capital Investments ($MM) are -1
Bellevue Life Sciences Acquisition Corp. ( BLAC ) Book Value ($MM) as of last quarter is 14
Bellevue Life Sciences Acquisition Corp. ( BLAC ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
Bellevue Life Sciences Acquisition Corp. ( BLAC ) has 0 million in cash on hand as of last quarter
Bellevue Life Sciences Acquisition Corp. ( BLAC ) has 3 million of liabilities due within 12 months, and long term debt 1 as of last quarter
Bellevue Life Sciences Acquisition Corp. ( BLAC ) has 4 common shares outstanding as of last quarter
Bellevue Life Sciences Acquisition Corp. ( BLAC ) has 0 million USD of preferred stock value
Academic Scores:
Bellevue Life Sciences Acquisition Corp. ( BLAC ) Altman Z-Score is 3.65 as of last quarter
Bellevue Life Sciences Acquisition Corp. ( BLAC ) Piotroski Score is 1.00 as of last quarter
Corporate Governance:
Bellevue Life Sciences Acquisition Corp. ( BLAC ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of Bellevue Life Sciences Acquisition Corp. ( BLAC ) for the amount of $ on
50.49% of Bellevue Life Sciences Acquisition Corp. ( BLAC ) is held by insiders, and 42.94% is held by institutions
Bellevue Life Sciences Acquisition Corp. ( BLAC ) went public on 2023-03-17
Other Bellevue Life Sciences Acquisition Corp. ( BLAC ) financial metrics:
FCF:-1.96
Unlevered Free Cash Flow:0.00
EPS:-0.23
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:16.06
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Bellevue Life Sciences Acquisition Corp. ( BLAC ) :
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.